11β-Hydroxysteroid dehydrogenase type 1 inhibition protects against the development of adverse metabolic and bone effects of prednisolone: A randomized, double-blind, placebo-controlled trial

Authors :: Jeremy Tomlinson
Rury R. Holman
Paul Stewart
Olorunsola F. Agbaje
Anastasia Arvaniti
Riccardo Pofi
Joanne E. Milton
Andrew Whittaker
Nantia Othonos
Ruth L. Coleman
Source :: Endocrine Abstracts.
Publication Year :: 2020
Publisher :: Bioscientifica, 2020.

Subjects :: Double blind
biology
business.industry
11β-hydroxysteroid dehydrogenase type 1
Placebo-controlled study
Prednisolone
biology.protein
Medicine
Pharmacology
business
medicine.drug

Full Text Access

Tools